Celgene – Cutting-Edge Biotechnology in Oncology

Celgene

Celgene is a prominent American biotechnology company founded in 1986 (part of Bristol-Myers Squibb since 2019). The manufacturer gained worldwide recognition for developing innovative therapies for complex oncological diseases (particularly blood cancers) and severe immunological conditions. Celgene's products represent cutting-edge targeted solutions, offering hope and extending the lives of patients with severe diagnoses worldwide.